Assessment of the Autophagy Biomarker Level In Diabetic Kidney Disease Patients

Abstract Introduction Diabetic nephropathy is the most common long-term complication of diabetes mellitus and one of its major complications is diabetic kidney disease which is a major cause of end-stage renal disease (ESRD). Recent studies suggested defective autophagy involved in the pathogenesis and progression of diabetic kidney disease. So, we aimed to assess the autophagy biomarker Beclin-1 level in diabetic kidney disease patients. Methods In a cross sectional study, we enrolled 100 patients with Diabetic Kidney Disease (DKD) referred to Ain Shams University hospital. The patients were divided into 5 groups according to the estimated glomerular filtration rate (eGFR). Each group consisted of 20 patients to Compare the level of serum Beclin-1 in different groups. Beclin 1 assay: Human Beclin 1 (BECN1) ELISA kit uses a double antibody sandwich enzyme linked immunosorbent assay (ELISA) to assay the level of Human Beclin 1 (BECN1) in samples. Results There was statistically significant difference between the studied groups (p < 0.001) regarding hemoglobin, creatinine, hemoglobin A1c, calcium, phosphate, protein creatinine ratio, eGFR, and Beclin-1 levels with highest value among group (2, 5, 4, 2, 5, 5, 5 and 5) respectively and lowest value among group (5, 1, 5, 5, 2, 1, 5 and 5) respectively. There was statistically significant inverse correlation between Beclin-1 and diabetes duration, creatinine, urea, CRP and protein creatinine ratio (r: −0.24; p = 0.026), (r: −0.44; p < 0.001), (r: −0.44; p < 0.001), (r: −0.52; p < 0.001), (r: −0.56; p < 0.001) respectively. There was statistically significant positive correlation between Beclin-1 and hemoglobin, calcium and eGFR (r: 0.242; p = 0.015), (r: 0.248; p = 0.013) and (r: 0.568; p < 0.001) respectively. At cutoff value equal to (3.3, 1.2, 1.8 and 1.1) Beclin-1 had sensitivity equal to (100%, 55%, 80% and 85%) respectively and specificity equal to (85%, 85%, 75% and 100%) respectively in prediction of CKD progression from (stage 1 to stage 2), (stage 2 to stage 3), (stage 3 to stage 4) and (stage 4 to stage 5) respectively. Conclusion In conclusion we found that eGFR was the most influential parameter affecting Beclin-1 level and by using multivariate model, linear regression analysis adjusted factors for confounders eGFR was the only factor which kept his significant correlation with Beclin-1.

Authors

Institutions

Publication Details

Journal
QJM
Published
2024-10-01
DOI
https://doi.org/10.1093/qjmed/hcae175.404
Primary Topic
Autophagy in Disease and Therapy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Assessment of the Autophagy Biomarker Level In Diabetic Kidney Disease Patients

Nahed Moawad Rakha, Saeed Abdelwahab Saeed, Ashraf Hassan Abdelmobdy, Khaled Mohamed
QJM
Autophagy in Disease and Therapy
article

Assessment of the Autophagy Biomarker Level In Diabetic Kidney Disease Patients

Nahed Moawad Rakha, Saeed Abdelwahab Saeed, Ashraf Hassan Abdelmobdy, Khaled Mohamed
article en

Abstract

Abstract Introduction Diabetic nephropathy is the most common long-term complication of diabetes mellitus and one of its major complications is diabetic kidney disease which is a major cause of end-stage renal disease (ESRD). Recent studies suggested defective autophagy involved in the pathogenesis and progression of diabetic kidney disease. So, we aimed to assess the autophagy biomarker Beclin-1 level in diabetic kidney disease patients. Methods In a cross sectional study, we enrolled 100 patients with Diabetic Kidney Disease (DKD) referred to Ain Shams University hospital. The patients were divided into 5 groups according to the estimated glomerular filtration rate (eGFR). Each group consisted of 20 patients to Compare the level of serum Beclin-1 in different groups. Beclin 1 assay: Human Beclin 1 (BECN1) ELISA kit uses a double antibody sandwich enzyme linked immunosorbent assay (ELISA) to assay the level of Human Beclin 1 (BECN1) in samples. Results There was statistically significant difference between the studied groups (p < 0.001) regarding hemoglobin, creatinine, hemoglobin A1c, calcium, phosphate, protein creatinine ratio, eGFR, and Beclin-1 levels with highest value among group (2, 5, 4, 2, 5, 5, 5 and 5) respectively and lowest value among group (5, 1, 5, 5, 2, 1, 5 and 5) respectively. There was statistically significant inverse correlation between Beclin-1 and diabetes duration, creatinine, urea, CRP and protein creatinine ratio (r: −0.24; p = 0.026), (r: −0.44; p < 0.001), (r: −0.44; p < 0.001), (r: −0.52; p < 0.001), (r: −0.56; p < 0.001) respectively. There was statistically significant positive correlation between Beclin-1 and hemoglobin, calcium and eGFR (r: 0.242; p = 0.015), (r: 0.248; p = 0.013) and (r: 0.568; p < 0.001) respectively. At cutoff value equal to (3.3, 1.2, 1.8 and 1.1) Beclin-1 had sensitivity equal to (100%, 55%, 80% and 85%) respectively and specificity equal to (85%, 85%, 75% and 100%) respectively in prediction of CKD progression from (stage 1 to stage 2), (stage 2 to stage 3), (stage 3 to stage 4) and (stage 4 to stage 5) respectively. Conclusion In conclusion we found that eGFR was the most influential parameter affecting Beclin-1 level and by using multivariate model, linear regression analysis adjusted factors for confounders eGFR was the only factor which kept his significant correlation with Beclin-1.

QJMVol. 117(Supplement_2)
Ain Shams University (EG)
Openalex Percentile: Top 68%
Autophagy in Disease and Therapy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.